✦ LIBER ✦

Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer

✍ Scribed by Elisabetta Munzone; Franco Nolé; Aron Goldhirsch; Edoardo Botteri; Angela Esposito; Laura Zorzino; Giuseppe Curigliano; Ida Minchella; Laura Adamoli; Maria Cristina Cassatella; Chiara Casadio; Maria Teresa Sandri

Book ID: 115075881
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 639 KB
Volume: 10
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2010.n.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation of HER2 status between prima

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

✍ Marta Pestrin; Silvia Bessi; Francesca Galardi; Mara Truglia; Annibale Biggeri; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 223 KB

HER2 status predicts the presence of cir

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

✍ Julie E. Lang; Kailash Mosalpuria; Massimo Cristofanilli; Savitri Krishnamurthy; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 209 KB

HER2 status of circulating tumor cells i

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

✍ Tanja Fehm; Volkmar Müller; Bahriye Aktas; Wolfgang Janni; Andreas Schneeweiss; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 230 KB

Comparison of estrogen and progesterone

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

✍ Bahriye Aktas; Volkmar Müller; Mitra Tewes; Julia Zeitz; Sabine Kasimir-Bauer; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Comparative Analysis Between the HER2 St

Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow

✍ C. Schindlbeck; W. Janni; N. Shabani; B. Rack; B. Gerber; M. Schmitt; N. Harbeck 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 122 KB

Phase II study of Docetaxel, Carboplatin

Phase II study of Docetaxel, Carboplatin, and Trastuzumab (THC) as first-line treatment in patients with HER-2 amplified advanced breast cancer. Changes in circulating tumor cells (CTC), total plasma DNA and circulating HER-2 ECD

✍ L. Dirix; Benoy; A. Prové; H. Elst; J. Vandebroeck; H. Wuyts; M. Philips; I. Del 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 119 KB